Literature DB >> 19434777

Rapid sequence induction in obstetrics revisited.

Lisa M Sharp1, David M Levy.   

Abstract

PURPOSE OF REVIEW: The regimen of thiopental, succinylcholine (SCh) and unsupplemented nitrous oxide/oxygen for Caesarean section was first introduced 50 years ago. This review examines which elements have endured, what has changed, and how practice might alter in the very near future. RECENT
FINDINGS: Sugammadex, a cyclodextrin, is capable of rapid reversal of profound rocuronium neuromuscular blockade.
SUMMARY: It is now feasible that SCh might be replaced with a high-dose rocuronium-sugammadex combination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19434777     DOI: 10.1097/aco.0b013e3283294c4a

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  5 in total

Review 1.  Review of evidences for management of rapid sequence spinal anesthesia for category one cesarean section, in resource limiting setting.

Authors:  Abatneh Feleke Agegnehu; Amare Hailekiros Gebregzi; Nigussie Simeneh Endalew
Journal:  Int J Surg Open       Date:  2020-09-03

2.  Anaesthesia for lower-segment caesarean section: Changing perspectives.

Authors:  Sean Brian Yeoh; Sng Ban Leong; Alex Sia Tiong Heng
Journal:  Indian J Anaesth       Date:  2010-09

3.  Anesthetic management of cesarean section in cases of placenta accreta, with versus without abdominal aortic balloon occlusion: study protocol for a randomized controlled trial.

Authors:  Qinjun Chu; Dan Shen; Long He; Hongwei Wang; Xianlan Zhao; Zhimin Chen; Yanli Wang; Wei Zhang
Journal:  Trials       Date:  2017-05-26       Impact factor: 2.279

Review 4.  Anaesthetic management of obstetric emergencies.

Authors:  Pradeep A Dongare; Madagondapalli S Nataraj
Journal:  Indian J Anaesth       Date:  2018-09

5.  Recovery of residual curarization after red blood cell transfusion.

Authors:  Veit-Simon Eckle; Eckhard Schmid; Tanja Fehm; Christian Grasshoff
Journal:  Med Sci Monit       Date:  2012-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.